The Procter & Gamble Company (NYSE: PG) enters Tuesday, November 25, 2025, under pressure in the stock market but with a surprisingly upbeat backdrop of analyst upgrades, brand innovation, and bullish options activity.
After a sharp drop in Monday’s session, PG last traded around $146.98, about 2.6% below its prior close near $150.92, with an intraday range roughly between $146.54 and $150.41 and heavy volume of about 13.8 million shares. [1]
Pre‑market trading early Tuesday shows PG in the high‑$140s, modestly above Monday’s close, suggesting a small rebound of roughly 1% as investors digest the sell‑off rather than panic‑dump the stock. [2]
At the same time, Procter & Gamble has just rolled out a new Aussie Ultra Wonder curl‑care collection, while a widely read Seeking Alpha note has upgraded PG to a “Buy” after “four years sideways,” arguing that the stock is now trading below its historical valuation multiples with a nearly 3% dividend yield. [3]
Below is a deep dive into PG’s price action today, the freshest news drivers around the stock, and what they could mean for short‑ and long‑term investors.
PG Stock Price Today: Key Numbers for November 25, 2025
Based on consolidated real‑time and recent closing data:
- Last regular-session price: about $146.98 per share [4]
- Prior close: roughly $150.92
- One‑day move (Monday): about –$3.94, or –2.6%
- Day range (latest session): approximately $146.54 – $150.41 [5]
- 52‑week range: about $144.09 – $180.43, putting PG not far above its 52‑week low [6]
- YTD total return (through Nov. 24): around –10%, with a trailing 12‑month total return near –15% [7]
- Market cap: approximately $343–350 billion
- Trailing P/E: around 21–22x earnings
- Forward P/E: about 20–21x
- Dividend: roughly $4.23 per share annually, for a yield close to 2.8–2.9% at current prices [8]
A FinanceCharts performance snapshot highlights how unusual this year has been for such a defensive blue chip: PG’s YTD total return of about –10% contrasts with a five‑year total return of more than 20% and a ten‑year return above 150%, underscoring how recent weakness follows a long run of compounding gains. [9]
Why Is PG Stock Under Pressure?
Monday’s sell‑off and Dow underperformance
On Monday (Nov. 24), PG was flagged as the worst‑performing component of the Dow Jones Industrial Average, trading down roughly 1.4% intraday at one point and extending an approximate 11% year‑to‑date decline. [10]
That slump continued into the close, with PG finishing around $147 and wiping out part of the modest rebound it had staged earlier in November.
Crucially, there was no new company‑specific negative surprise on Monday:
- The latest earnings report (on October 24) was actually better than expected. [11]
- The company has maintained its fiscal 2026 guidance for both sales growth and earnings per share. [12]
Instead, Monday’s move appears to be part of a broader re‑rating of defensive consumer‑staples names, as investors wrestle with tariff headlines, slower volume growth in mature markets and a shift toward higher‑beta sectors after a strong earnings season.
Fresh News Driving the Narrative on November 25, 2025
Even without a new earnings release today, there’s been a flurry of brand, analyst, and options‑flow stories around Procter & Gamble in the last few days. These are what investors are watching this morning.
1. Aussie launches Ultra Wonder curl collection
P&G’s Aussie brand has just launched Aussie Ultra Wonder, a new curl‑care line aimed at consumers looking for multi‑tasking, salon‑style results at mass‑market prices:
- The collection features three “multi‑benefit” products designed to simplify curly‑hair routines while combining moisture, frizz control and definition in fewer steps. [13]
- The launch comes via a Business Wire press release dated November 24, 2025, and is being cross‑distributed on financial and news portals including Yahoo Finance and StockTitan. [14]
While a single product line won’t move PG’s $340‑plus‑billion valuation on its own, it reinforces the core bull case: P&G continues to lean into premium innovation in hair care, a category where brands like Aussie and Pantene give it strong pricing power and brand recognition.
2. Seeking Alpha upgrade: “Nothing Not To Like After 4 Years Sideways”
Over the weekend, an influential Seeking Alpha note titled “Procter & Gamble: Nothing Not To Like After 4 Years Sideways (Rating Upgrade)” upgraded PG to a Buy. [15]
Key points from the summary:
- The author argues that PG now trades below its historical P/E averages.
- The stock’s roughly 2.8% dividend yield sits above its own five‑year average and compares favorably to many peers. [16]
- The article claims that several common bearish narratives around PG – including concerns about muted growth and tariff exposure – may be overstated.
This upgrade comes on the heels of other recent research pieces that paint a mixed but broadly constructive picture:
- Another Seeking Alpha article from November 22 titled “Strong Brand, Stable Margins, But Limited Near‑Term Upside” takes a more cautious tone, suggesting PG is a hold while acknowledging strong margins and brand power. [17]
- TipRanks highlighted PG as “primed for a wake‑up call” roughly a week ago, pointing to waning consumer sentiment but also to the stock’s long‑term resilience. [18]
Net‑net, recent independent research has shifted from “fully priced” toward “reasonable value”, even as the stock continues to drift near 52‑week lows.
3. Zacks and 24/7 Wall St: Dividend‑and‑defensive story stays intact
On November 21, Zacks added more fuel to the long‑term case with a piece titled “Why Procter & Gamble (PG) is a Top Stock for the Long‑Term”, highlighting PG’s inclusion in the Zacks Focus List of stocks expected to outperform over the next 12 months. [19]
Zacks emphasizes:
- P&G’s consistent earnings profile,
- its defensive position in consumer staples, and
- a positive earnings‑revision trend, which tends to be supportive for share prices.
Around the same time, 24/7 Wall St featured PG in “3 High‑Yield Consumer Staples Stocks To Buy Now,” underscoring its 135‑year dividend history and 69 consecutive years of dividend hikes. [20]
Together, these articles are reinforcing PG’s identity as a “sleep‑at‑night” dividend aristocrat, even as the share price stumbles in the short term.
4. Unusual options activity: whales leaning bullish
Benzinga reported on November 21 that “whales with a lot of money to spend” have taken a noticeably bullish stance on PG options. [21]
From that options‑flow analysis:
- The system detected 10 large PG option trades in the period reviewed.
- About 70% of those trades were bullish, with 8 call contracts (~$383,000 notional) vs. 2 put trades (~$88,000).
- The trades cluster around strike prices between $130 and $180, roughly mapping out where these large traders see potential value over the next several months. [22]
While options flow is not destiny, a bullish skew in whale trades can signal that sophisticated traders view current levels as attractive for upside exposure or at least see limited additional downside.
5. Institutional flows: more buyers than sellers in recent filings
New 13F‑driven coverage from MarketBeat over the last couple of days highlights net institutional accumulation:
- CreativeOne Wealth LLC boosted its PG position by 39.7%, buying nearly 18,700 shares to bring its stake to over 65,000 shares, valued around $10.5 million at the end of the quarter. [23]
- Longfellow Investment Management increased its holdings by 73%, lifting its PG stake to about 4,100 shares, worth roughly $655,000. [24]
- MarketBeat’s round‑up notes that institutions and hedge funds collectively own around two‑thirds of PG’s float. [25]
Some insiders have sold shares recently (including the CEO and CFO), but those trades are small relative to institutional ownership and appear to be routine portfolio‑management transactions rather than major strategic shifts. [26]
Earnings and Tariff Backdrop: Fundamentals Still Solid
The most important hard news that still frames PG’s stock today remains its fiscal 2026 first‑quarter report on October 24, 2025:
- Core EPS: about $1.99, beating consensus estimates near $1.90.
- Revenue: roughly $22.4 billion, up around 3% year‑over‑year and slightly ahead of Wall Street forecasts. [27]
- Tariff outlook: P&G cut its projected tariff‑related after‑tax costs for fiscal 2026 from roughly $800 million to about $400 million, while still highlighting tariffs as a key risk to monitor. [28]
- Guidance: Management reaffirmed fiscal 2026 targets, calling for 1–5% sales growth and core EPS in the $6.83–$7.09 range. [29]
Financially, P&G remains a profit machine:
- Fiscal 2025 revenue came in around $84.3 billion, with net income of roughly $15.7–$16.0 billion, implying a net margin close to 19%. [30]
- The company continues to generate strong operating cash flow (about $17–18 billion per year) and returns a large portion of that to shareholders via dividends and buybacks. [31]
Earlier in 2025, P&G also announced a plan to cut roughly 7,000 non‑manufacturing jobs – about 15% of such roles – over the next two years to streamline operations and offset cost pressures, a move expected to cost up to $1–1.6 billion before taxes but improve long‑term efficiency. [32]
The overall picture: fundamentals are healthy, but the market is still recalibrating how much it wants to pay for slow‑and‑steady growth in a higher‑tariff, higher‑rate world.
Legal and Reputational Risk: Kid’s Crest Lawsuit
One lingering risk item in the background:
- Earlier this month, a U.S. judge ruled that P&G must face a lawsuit alleging that the packaging for Kid’s Crest toothpaste suggests children can safely use more toothpaste than is actually recommended. [33]
The case is at a relatively early stage, and no damages have been awarded. For now, the impact appears more reputational and regulatory than financial, but investors are watching closely for:
- Any potential changes in product labeling,
- Broader scrutiny of oral‑care marketing claims, and
- Whether the case encourages similar suits in other product categories.
Is Procter & Gamble Stock Cheap Yet?
From a valuation standpoint, PG now looks more interesting than it did earlier this year, but it isn’t a screaming deep‑value play.
Key valuation markers today: [34]
- Trailing P/E: ~21–22x
- Forward P/E: ~20–21x
- Dividend yield: ~2.8–2.9%, above the S&P 500 yield and slightly above PG’s five‑year average
- YTD total return: about –10%, versus a positive double‑digit five‑year total return
Analysts overall remain constructive:
- StockAnalysis aggregates 14 analyst ratings, with an average recommendation of “Buy” and a 12‑month price target around $174, implying roughly 18–19% upside from today’s levels. [35]
- Fintel’s coverage of the sell‑side shows a mix of Neutral, Equal‑Weight, Overweight and Buy ratings from major firms like JP Morgan, Wells Fargo, UBS, Barclays and BofA, with most still expecting modest upside from here. [36]
Combined with the bullish tilt in recent options activity and steady institutional accumulation, that suggests the market is not abandoning PG – it’s repricing it closer to a “classic defensive compounder” than a growth stock.
What Today’s Setup Means for Investors
For traders watching PG today, November 25, 2025:
- The stock is trying to stabilize in the high‑$140s after Monday’s drop. [37]
- No fresh negative corporate news has hit the tape this morning; instead, headlines are about brand launches, upbeat analyst commentary, and bullish options flows. [38]
For longer‑term investors:
- Pros:
- World‑class portfolio of brands (Tide, Gillette, Pampers, Pantene, Crest, and many more). [39]
- Strong margins, cash flow and dividend growth, including 69 straight years of dividend increases. [40]
- A more favorable valuation vs. its own history, and evidence of ongoing innovation (Aussie, Pantene, Pampers launches in November alone). [41]
- Cons / Risks:
For now, the message the market seems to be sending is:
PG is still a high‑quality, dividend‑rich defensive stock – but investors are no longer willing to pay peak multiples for slow‑growing staples, especially with tariffs and consumer‑spending uncertainty in the background.
Bottom Line
On November 25, 2025, Procter & Gamble stock is:
- Trading near the low end of its 52‑week range,
- Down about 10% year‑to‑date,
- Yet supported by solid fundamentals, upbeat analyst coverage, fresh brand innovation, and visible institutional and options‑market interest.
For investors, today’s setup looks less like a “PG is broken” story and more like a classic defensive compounder temporarily out of favor as capital rotates elsewhere.
As always, this article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Do your own research, consider your risk tolerance and time horizon, and, if necessary, consult a qualified financial adviser before making any investment decisions.
References
1. stockanalysis.com, 2. marketchameleon.com, 3. us.pg.com, 4. stockanalysis.com, 5. stockanalysis.com, 6. stockanalysis.com, 7. www.financecharts.com, 8. stockanalysis.com, 9. www.financecharts.com, 10. www.nasdaq.com, 11. www.pginvestor.com, 12. www.pginvestor.com, 13. us.pg.com, 14. finance.yahoo.com, 15. seekingalpha.com, 16. stockanalysis.com, 17. stockanalysis.com, 18. www.tipranks.com, 19. finance.yahoo.com, 20. 247wallst.com, 21. www.benzinga.com, 22. www.benzinga.com, 23. www.marketbeat.com, 24. www.marketbeat.com, 25. www.marketbeat.com, 26. www.marketbeat.com, 27. www.pginvestor.com, 28. www.barrons.com, 29. www.businesswire.com, 30. www.reuters.com, 31. www.reuters.com, 32. www.ft.com, 33. www.reuters.com, 34. stockanalysis.com, 35. stockanalysis.com, 36. fintel.io, 37. marketchameleon.com, 38. us.pg.com, 39. www.reuters.com, 40. www.businesswire.com, 41. us.pg.com, 42. www.barrons.com, 43. www.ft.com, 44. www.reuters.com
